It reported earnings +74% on +14% sales revenues for the Sep '18 quarter versus the year ago period. Quarterly comparisons have shown strong earnings increases above the +25% minimum guideline (C criteria) with strong sales revenues growth. Its small supply of only 52.6 million outstanding shares (S criteria) can contribute to greater price volatility in the event of institutional buying or selling. Annual earnings (A criteria) history has been strong after a small downturn in FY '15.
The number of top-rated funds owning its shares rose from 455 in Dec '17 to 522 in Sep '18, a reassuring sign concerning the I criteria. It has earned an A Timeliness rating and a B Sponsorship Rating. The current Up/Down Volume ration of 1.1 is an unbiased indication its shares have been under slight accumulation over the past 50 days.
Charts courtesy of www.stockcharts.com
